Pharma Bio OTC Stock Insiders

Pharma Bio Management Team Effectiveness

The company has return on total asset (ROA) of 0.033 % which means that it generated a profit of $0.033 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0568 %, meaning that it created $0.0568 on every $100 dollars invested by stockholders. Pharma Bio's management efficiency ratios could be used to measure how well Pharma Bio manages its routine affairs as well as how well it operates its assets and liabilities.

Pharma Bio Workforce Comparison

The company has Profit Margin (PM) of 0.05 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.06 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.06.

Pharma Bio Serv Benchmark Summation

Pharma Bio Notable Stakeholders

The success or failure of an entity such as Pharma Bio Serv often depends on how effective the management is. Pharma Bio management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Pharma management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Pharma management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

The data published in Pharma Bio's official financial statements typically reflect Pharma Bio's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Pharma Bio's quantitative information. For example, before you start analyzing numbers published by Pharma accountants, it's essential to understand Pharma Bio's liquidity, profitability, and earnings quality within the context of the Life Sciences Tools & Services space in which it operates.

Please note, the imprecision that can be found in Pharma Bio's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Pharma Bio Serv. Check Pharma Bio's Beneish M Score to see the likelihood of Pharma Bio's management manipulating its earnings.

When running Pharma Bio's price analysis, check to measure Pharma Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharma Bio is operating at the current time. Most of Pharma Bio's value examination focuses on studying past and present price action to predict the probability of Pharma Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharma Bio's price. Additionally, you may evaluate how the addition of Pharma Bio to your portfolios can decrease your overall portfolio volatility.